Clinical Chemistry and Laboratory Medicine (CCLM) · 1982 · 14 citations · 4 references
MedicineBiochemistryNephrologyEnzymologyRenal PathologyRenal PathophysiologyGlomerular DiseasesNephrotic SyndromeRenal DiseaseUrinary ExcretionKidney DiseasesPh DependenceRenal Enzyme MarkersUrinary Excretion Kinetics
We measured the activity of angiotensin converting enzyme (ED 3.4.15.1) in urine samples from normal subjects and patients with nephrotic syndrome and chronic glomerulonephritis. Urinary excretion of angiotensin converting enzyme in patients with nephrotic syndrome (1.58 +/- 0.50 (SD) units/day; n = 15) and chronic glomerulonephritis (1.01 +/- 0.45 units/day; n = 12) was significantly increased compared with normal subjects (0.38 +/- 0.10 units/day; n = 18). It was demonstrated that a high molecular weight form of the enzyme (more than 400000) was mainly excreted in urines from patients with nephrotic syndrome. After trypsin treatment, this form was altered to a low molecular weight form (290000). These two different forms of urinary angiotensin converting enzyme were compared with the enzyme purified from human kidney, and found to be identical with respect to Km values (2 mmol/l), pH optimum (pH 8.3), chloride ion dependency (0.8 mol/l), inhibitory effect of captopril (I50, 21 nmol/l), and behavior towards antiserum to human kidney angiotensin converting enzyme.
4
Angiotensin I-converting enzyme in human urine
Tatsuo Kokubu, I Kato, Kazutaka Nishimura et al. · Clinica Chimica Acta · 1978 · 42 citations
B. Baggio, S. Favaro, S. Cantaro et al. · Clinica Chimica Acta · 1981 · 24 citations
Medicine, Nephrology, Urology +10